Elecsys Ferritin 4491785160Recalls & reported problems
Roche Diagnostics GmbH · Class 2
All models of Elecsys Ferritin (3)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04015630938957), received between Jun 22, 2023 and Sep 18, 2024 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results2
- Non Reproducible Results1
- Unable to Obtain Readings1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 18, 2024Low Test Results; Low Test Results
THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS FERRITIN RESULTS FOR 1 PATIENT SERUM SAMPLE ON A COBAS 6000 E601 MODULE. THE INITIAL FERRITIN RESULT WAS 1.33 NG/L. THE CUSTOMER QUESTIONED THE INITIAL RESULT AS IT DID NOT MATCH THE PATIENT'S PREVIOUS RESULT. THE SAMPLE WAS REPEATED AND THE RESULT WAS 988.4 NG/L. THE SAMPLE WAS ALSO REPEATED ON ANOTHER E601 ANALYZER AND THE RESULT WAS 1010 NG/L. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE REPEAT RESULTS WERE DEEMED CORRECT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20250780 ↗MalfunctionDec 18, 2023Low Test Results; Non Reproducible Results; Low Test Results; Non Reproducible Results
THERE WAS AN ALLEGATION OF QUESTIONABLE RESULTS FROM THE COBAS 6000 E601 MODULE. PATIENT 1 INITIAL HCG+BETA ELECSYS RESULT WAS 3653 MIU/ML AND THE REPEAT RESULT WAS 8505 MIU/ML. PATIENT 2 INITIAL FERRITIN RESULT WAS 1578 NG/ML AND THE REPEAT RESULT WAS 3036 NG/ML.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18346976 ↗MalfunctionJun 22, 2023Unable to Obtain Readings; Unable to Obtain Readings
WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT'S SERUM SAMPLE TESTED WITH ELECSYS FERRITIN (FERR) ASSAY ON A COBAS 6000 COBAS E601 IMMUNOASSAY ANALYZER. INITIAL RESULT: 0.768 NG/ML REPEAT RESULT: 18.65 NG/ML THE QUESTIONABLE RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE CUSTOMER NOTICED THE QUESTIONABLE RESULT WHILE REVIEWING THE TESTING AND THEREFORE, REPEATED THE SAMPLE. THE REPEAT RESULT WAS DEEMED TO BE CORRECT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17183791 ↗
Other Radioimmunoassay (two-site solid phase), ferritin devices
- Dimension® Flex® reagent cartridge FERR 10444946Siemens Healthcare Diagnostics Inc. · Radioimmunoassay (two-site solid phase), ferritin1 recall0 reports
- Elecsys Ferritin 07027273190Roche Diagnostics GmbH · Radioimmunoassay (two-site solid phase), ferritin22 reports
- Elecsys Ferritin 3737551160Roche Diagnostics GmbH · Radioimmunoassay (two-site solid phase), ferritin4 reports
- Access Ferritin 33020Beckman Coulter, Inc. · Radioimmunoassay (Two-Site Solid Phase), Ferritin1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page